Incyte (INCY) Current Deferred Tax Assets (2013 - 2015)
Incyte's (INCY) quarterly Current Deferred Tax Assets came in at $9.7 million in Q3 2015, up 1153.16% YoY from $775000.0 in Q3 2014, and up 25.72% on a QoQ basis from $7.7 million in Q2 2015.
Analysis
Incyte (INCY) Current Deferred Tax Assets (2013 - 2015) Analysis & Trends
Incyte (INCY) has 3 years of Current Deferred Tax Assets data on file, last reported at $9.7 million in Q3 2015.
- Quarterly Current Deferred Tax Assets rose 1153.16% year-over-year to $9.7 million in Q3 2015, while the trailing twelve-month figure through Sep 2015 was $9.7 million (up 1153.16% YoY) and the FY2014 annual result came in at $19.6 million, up 2094.53% from the prior year.
- Current Deferred Tax Assets climbed to $9.7 million in Q3 2015, from $7.7 million in the prior quarter.
- In the past five years, Current Deferred Tax Assets ranged from a high of $19.6 million in Q4 2014 to a low of $775000.0 in Q3 2014.
- A 3-year average of $5.8 million and a median of $3.5 million in 2014 frame the typical range for Current Deferred Tax Assets.
- Annual changes were most pronounced in 2014 — Current Deferred Tax Assets surged 2094.53% — and 2015, when it jumped 575.45%.
- Tracing INCY's Current Deferred Tax Assets over 3 years: stood at $895000.0 in 2013, then surged by 2094.53% to $19.6 million in 2014, then sank by 50.55% to $9.7 million in 2015.
- The last three Current Deferred Tax Assets figures came in at $9.7 million (Q3 2015), $7.7 million (Q2 2015), and $6.0 million (Q1 2015), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Incyte | 25.44 Bn | 20.91 Bn | 1.57 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2015 | 9.71 Mn |
| Jun 30, 2015 | 7.73 Mn |
| Mar 31, 2015 | 6.03 Mn |
| Dec 31, 2014 | 19.64 Mn |
| Sep 30, 2014 | 775,000.00 |
| Jun 30, 2014 | 900,000.00 |
| Mar 31, 2014 | 892,000.00 |
| Dec 31, 2013 | 895,000.00 |